BioCardia, Inc. Warrant
BCDAW
BCDAW was delisted on the 2nd of August, 2024.
1 hedge funds and large institutions have $63K invested in BioCardia, Inc. Warrant in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
21% more capital invested
Capital invested by funds: $52K → $63K (+$11K)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
50% less funds holding
Funds holding: 2 → 1 (-1)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Osaic Holdings
Scottsdale,
Arizona
| $63K | +$63.3K | +63,088 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$1K | -1,105 | Closed |
|
BCDAW Hedge Fund Activity: Q1 2020 in Review
1 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q1 2020, worth a combined $63K — up 21% from $52K a quarter earlier.
Fund positioning in BCDAW was balanced in Q1 2020: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was UBS Group, exiting entirely with an estimated $1K sold.
- 1 institutional investor held BioCardia, Inc. Warrant (BCDAW) as of Q1 2020, down from 2 in Q4 2019.
- Funds reported $63K of BioCardia, Inc. Warrant stock for Q1 2020, up 21% quarter-over-quarter.
- 1 fund opened new BioCardia, Inc. Warrant positions in Q1 2020 and 1 closed out, a net change of 0 holders.
- The largest BioCardia, Inc. Warrant seller in Q1 2020 was UBS Group, an estimated $1K sold.
Based on aggregated 13F filings for Q1 2020.